Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	37.38	24.95	18.16
Graham Fair Price	-0.19	42.25	42.33
PEG	27289.86	18.11	0.07
Price/Book	12.57	1.53	1.36
Price/Cash Flow	-59.16	-20.63	50.52
Prices/Earnings	11.39	12.32	11.06
Price/Sales	9.84	5.68	5.17
Price/FCF	-59.16	-20.63	50.52
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-0.35	0.81	0.81
Operating Margin	1.80	0.18	0.18
ROA	-0.73	< 0.005	< 0.005
ROE	0.03	0.03	1.06
ROIC	0.03	0.03	-0.83
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	1.09	< 0.005	476201.03
Dividends QOQ	0.06	0.48	745.52
EBIT QOQ	0.61	0.04	-93.58
EPS QOQ	1.67	< 0.005	-99.59
FCF QOQ	1.30	-3.75	188.91
Revenue QOQ	0.10	0.02	-78.69
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	1229.94	0.00	inf
Days Sales Outstanding (DSO)	81.30	97.27	19.65
Inventory Turnover	0.07	0.00	inf
Debt/Capitalization	0.24	0.24	-0.74
Quick Ratio	2.68	7.62	184.43
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	50.94	50.58	-0.71
Cash	47.28	47.70	0.91
Capex	-0.12	-0.09	25.83
Free Cash Flow	1.37	-3.75	173.67
Revenue	13.37	13.61	1.76
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.13	5.74	169.34
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-7.94	-3.60	54.61
Naive Interpretation	Member

06 - Financial Health · Bad

Rating